Glatiramer Acetate-impurities | Pharmaffiliates

glatiramer acetate and its Impurities

Glatiramer Acetate used to treat multiple sclerosis. It is an immunomodulator medication. Glatiramer acetate is approved in the United States to reduce the frequency of relapses, but not for reducing the progression of disability. Reference standards of Glatiramer Acetate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 4 results for glatiramer acetate Impurities
PA 07 48000

Glatiramer Acetate - API

Glatiramer Acetate


  • Catalogue No.:PA 07 48000

  • CAS :

    147245-92-9

  • Molecular Formula : C25H45N5O13

  • Molecular Weight : 623.65

PA 07 48510

3-Bromo-L-tyrosine

3-Bromo-L-tyrosine


  • Catalogue No.:PA 07 48510

  • CAS :

    38739-13-8

  • Molecular Formula : C9H10BrNO3

  • Molecular Weight : 260.08

PAI 07 008010

Benzyl (S)-5-(((S)-1-(((S)-3-(4-hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoate

Benzyl (S)-5-(((S)-1-(((S)-3-(4-hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoate


  • Catalogue No.:PAI 07 008010

  • CAS :

    NA

  • Molecular Formula : C32H41F3N6O8

  • Molecular Weight : 694.71

PAI 07 008020

(S)-5-(((S)-1-(((S)-3-(4-Hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoic acid

(S)-5-(((S)-1-(((S)-3-(4-Hydroxyphenyl)-1-(methylamino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)amino)-4-((S)-2-(methylamino)-4-(2,2,2-trifluoroacetamido)butanamido)-5-oxopentanoic acid


  • Catalogue No.:PAI 07 008020

  • CAS :

    NA

  • Molecular Formula : C25H35F3N6O8

  • Molecular Weight : 604.58